Omid Seidizadeh/LinkedIn
Oct 23, 2025, 06:48
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”Happy to share our new publication in RPTH Journal
Our study integrates clinical, biochemical, and structural data to uncover how A2 domain variants drive disease through impaired multimerization, altered proteolysis, and increased clearance.
A great collaboration with Dr. Luca Mollica and the team!”
Read the full article in RPTH.
Article: Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
Authors: Omid Seidizadeh, Luca Mollica, Davide Giana, Luciano Baronciani, Paola Colpani, Lea Sicuro, Andrea Cairo, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy
-
Jun 26, 2026, 15:51Heghine Khachatryan: Willebrand Disease – Similar Bleeding Phenotype, Distinct Pathophysiology
-
Jun 26, 2026, 15:37Von Willebrand Disease: New Diagnostic Approaches
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment